| Id |
Subject |
Object |
Predicate |
Lexical cue |
| tok1 |
0-13 |
NNP |
denotes |
Network-based |
| tok2 |
14-18 |
NN |
denotes |
drug |
| tok3 |
19-30 |
VBG |
denotes |
repurposing |
| event13 |
19-30 |
OCCURRENCE |
denotes |
repurposing |
| tok4 |
31-34 |
IN |
denotes |
for |
| tok5 |
35-40 |
NN |
denotes |
novel |
| tok6 |
41-52 |
JJ |
denotes |
coronavirus |
| tok7 |
53-57 |
CD |
denotes |
2019 |
| lookup1 |
53-57 |
year |
denotes |
2019 |
| tok8 |
57-58 |
: |
denotes |
- |
| tok9 |
58-62 |
NN |
denotes |
nCoV |
| tok10 |
62-63 |
NN |
denotes |
/ |
| tok11 |
63-72 |
NNP |
denotes |
SARS-CoV- |
| tok12 |
72-73 |
CD |
denotes |
2 |
| tok13 |
73-74 |
. |
denotes |
. |
| tok14 |
75-80 |
JJ |
denotes |
Human |
| tok15 |
81-94 |
NNS |
denotes |
coronaviruses |
| tok16 |
95-96 |
( |
denotes |
( |
| tok17 |
96-101 |
NNP |
denotes |
HCoVs |
| tok18 |
101-102 |
) |
denotes |
) |
| tok19 |
102-103 |
, |
denotes |
, |
| tok20 |
104-113 |
VBG |
denotes |
including |
| tok21 |
114-120 |
JJ |
denotes |
severe |
| tok22 |
121-126 |
JJ |
denotes |
acute |
| tok23 |
127-138 |
JJ |
denotes |
respiratory |
| tok24 |
139-147 |
NN |
denotes |
syndrome |
| tok25 |
148-159 |
JJ |
denotes |
coronavirus |
| tok26 |
160-161 |
( |
denotes |
( |
| tok27 |
161-169 |
NNP |
denotes |
SARS-CoV |
| tok28 |
169-170 |
) |
denotes |
) |
| tok29 |
171-174 |
CC |
denotes |
and |
| tok30 |
175-179 |
CD |
denotes |
2019 |
| lookup2 |
175-179 |
year |
denotes |
2019 |
| tok31 |
180-185 |
NN |
denotes |
novel |
| tok32 |
186-197 |
JJ |
denotes |
coronavirus |
| tok33 |
198-199 |
( |
denotes |
( |
| tok34 |
199-203 |
CD |
denotes |
2019 |
| lookup3 |
199-203 |
year |
denotes |
2019 |
| tok35 |
203-204 |
: |
denotes |
- |
| tok36 |
204-208 |
NN |
denotes |
nCoV |
| tok37 |
208-209 |
, |
denotes |
, |
| tok38 |
210-214 |
RB |
denotes |
also |
| tok39 |
215-220 |
VBN |
denotes |
known |
| event6 |
215-220 |
OCCURRENCE |
denotes |
known |
| tok40 |
221-223 |
IN |
denotes |
as |
| lookup4 |
221-223 |
country_code |
denotes |
as |
| tok41 |
224-233 |
NNP |
denotes |
SARS-CoV- |
| tok42 |
233-234 |
LS |
denotes |
2 |
| tok43 |
234-235 |
) |
denotes |
) |
| tok44 |
235-236 |
, |
denotes |
, |
| tok45 |
237-241 |
VB |
denotes |
lead |
| event11 |
237-241 |
OCCURRENCE |
denotes |
lead |
| tok46 |
242-248 |
JJ |
denotes |
global |
| tok47 |
249-258 |
NNS |
denotes |
epidemics |
| tok48 |
259-263 |
IN |
denotes |
with |
| tok49 |
264-268 |
JJ |
denotes |
high |
| tok50 |
269-278 |
NN |
denotes |
morbidity |
| tok51 |
279-282 |
CC |
denotes |
and |
| tok52 |
283-292 |
NN |
denotes |
mortality |
| tok53 |
292-293 |
. |
denotes |
. |
| tok54 |
294-301 |
RB |
denotes |
However |
| tok55 |
301-302 |
, |
denotes |
, |
| tok56 |
303-308 |
EX |
denotes |
there |
| tok57 |
309-312 |
VBP |
denotes |
are |
| tok58 |
313-322 |
RB |
denotes |
currently |
| tok59 |
323-325 |
DT |
denotes |
no |
| lookup5 |
323-325 |
country_code |
denotes |
no |
| tok60 |
326-335 |
JJ |
denotes |
effective |
| tok61 |
336-341 |
NNS |
denotes |
drugs |
| tok62 |
342-351 |
VBG |
denotes |
targeting |
| event3 |
342-351 |
OCCURRENCE |
denotes |
targeting |
| tok63 |
352-356 |
CD |
denotes |
2019 |
| lookup6 |
352-356 |
year |
denotes |
2019 |
| tok64 |
356-357 |
: |
denotes |
- |
| tok65 |
357-361 |
NN |
denotes |
nCoV |
| tok66 |
361-362 |
NN |
denotes |
/ |
| tok67 |
362-371 |
NNP |
denotes |
SARS-CoV- |
| tok68 |
371-372 |
CD |
denotes |
2 |
| tok69 |
372-373 |
. |
denotes |
. |
| tok70 |
374-378 |
NNP |
denotes |
Drug |
| tok71 |
379-390 |
VBG |
denotes |
repurposing |
| event15 |
379-390 |
OCCURRENCE |
denotes |
repurposing |
| tok72 |
390-391 |
, |
denotes |
, |
| tok73 |
392-404 |
VBG |
denotes |
representing |
| event12 |
392-404 |
OCCURRENCE |
denotes |
representing |
| tok74 |
405-407 |
IN |
denotes |
as |
| lookup7 |
405-407 |
country_code |
denotes |
as |
| tok75 |
408-410 |
DT |
denotes |
an |
| lookup8 |
408-410 |
country_code |
denotes |
an |
| tok76 |
411-420 |
JJ |
denotes |
effective |
| tok77 |
421-425 |
NN |
denotes |
drug |
| tok78 |
426-435 |
NN |
denotes |
discovery |
| tok79 |
436-444 |
NN |
denotes |
strategy |
| tok80 |
445-449 |
IN |
denotes |
from |
| tok81 |
450-458 |
VBG |
denotes |
existing |
| tok82 |
459-464 |
NNS |
denotes |
drugs |
| tok83 |
464-465 |
, |
denotes |
, |
| tok84 |
466-471 |
MD |
denotes |
could |
| tok85 |
472-479 |
VB |
denotes |
shorten |
| event7 |
472-479 |
OCCURRENCE |
denotes |
shorten |
| tok86 |
480-483 |
DT |
denotes |
the |
| tok87 |
484-488 |
NN |
denotes |
time |
| tok88 |
489-492 |
CC |
denotes |
and |
| tok89 |
493-499 |
VB |
denotes |
reduce |
| event9 |
493-499 |
OCCURRENCE |
denotes |
reduce |
| tok90 |
500-503 |
DT |
denotes |
the |
| tok91 |
504-508 |
NN |
denotes |
cost |
| tok92 |
509-517 |
VBN |
denotes |
compared |
| tok93 |
518-520 |
TO |
denotes |
to |
| lookup9 |
518-520 |
country_code |
denotes |
to |
| tok94 |
521-523 |
IN |
denotes |
de |
| lookup10 |
521-523 |
country_code |
denotes |
de |
| lookup11 |
521-523 |
surname |
denotes |
de |
| tok95 |
524-528 |
NN |
denotes |
novo |
| tok96 |
529-533 |
NN |
denotes |
drug |
| tok97 |
534-543 |
NN |
denotes |
discovery |
| tok98 |
543-544 |
. |
denotes |
. |
| tok99 |
545-547 |
IN |
denotes |
In |
| tok100 |
548-552 |
DT |
denotes |
this |
| lookup12 |
548-552 |
time_modifier |
denotes |
this |
| tok101 |
553-558 |
NN |
denotes |
study |
| tok102 |
558-559 |
, |
denotes |
, |
| tok103 |
560-562 |
PRP |
denotes |
we |
| tok104 |
563-570 |
VB |
denotes |
present |
| event5 |
563-570 |
OCCURRENCE |
denotes |
present |
| tok105 |
571-573 |
DT |
denotes |
an |
| lookup13 |
571-573 |
country_code |
denotes |
an |
| tok106 |
574-585 |
JJ |
denotes |
integrative |
| tok107 |
585-586 |
, |
denotes |
, |
| tok108 |
587-596 |
JJ |
denotes |
antiviral |
| tok109 |
597-601 |
NN |
denotes |
drug |
| tok110 |
602-613 |
VBG |
denotes |
repurposing |
| tok111 |
614-625 |
NN |
denotes |
methodology |
| tok112 |
626-638 |
VBG |
denotes |
implementing |
| event1 |
626-638 |
OCCURRENCE |
denotes |
implementing |
| tok113 |
639-640 |
DT |
denotes |
a |
| tok114 |
641-648 |
NNS |
denotes |
systems |
| tok115 |
649-667 |
JJ |
denotes |
pharmacology-based |
| tok116 |
668-675 |
NN |
denotes |
network |
| tok117 |
676-684 |
NN |
denotes |
medicine |
| tok118 |
685-693 |
NN |
denotes |
platform |
| tok119 |
693-694 |
, |
denotes |
, |
| tok120 |
695-706 |
VBG |
denotes |
quantifying |
| event4 |
695-706 |
OCCURRENCE |
denotes |
quantifying |
| tok121 |
707-710 |
DT |
denotes |
the |
| tok122 |
711-720 |
NN |
denotes |
interplay |
| tok123 |
721-728 |
IN |
denotes |
between |
| tok124 |
729-732 |
DT |
denotes |
the |
| tok125 |
733-742 |
NNP |
denotes |
HCoV-host |
| tok126 |
743-754 |
NN |
denotes |
interactome |
| tok127 |
755-758 |
CC |
denotes |
and |
| tok128 |
759-763 |
NN |
denotes |
drug |
| tok129 |
764-771 |
NNS |
denotes |
targets |
| tok130 |
772-774 |
IN |
denotes |
in |
| lookup14 |
772-774 |
country_code |
denotes |
in |
| tok131 |
775-778 |
DT |
denotes |
the |
| tok132 |
779-784 |
JJ |
denotes |
human |
| tok133 |
785-800 |
JJ |
denotes |
protein-protein |
| tok134 |
801-812 |
NN |
denotes |
interaction |
| tok135 |
813-820 |
NN |
denotes |
network |
| tok136 |
820-821 |
. |
denotes |
. |
| tok137 |
822-834 |
NNP |
denotes |
Phylogenetic |
| tok138 |
835-843 |
NNS |
denotes |
analyses |
| tok139 |
844-846 |
IN |
denotes |
of |
| tok140 |
847-849 |
CD |
denotes |
15 |
| tok141 |
850-854 |
NNP |
denotes |
HCoV |
| tok142 |
855-860 |
JJ |
denotes |
whole |
| tok143 |
861-868 |
NNS |
denotes |
genomes |
| tok144 |
869-875 |
VBP |
denotes |
reveal |
| tok145 |
876-880 |
IN |
denotes |
that |
| tok146 |
881-885 |
CD |
denotes |
2019 |
| lookup15 |
881-885 |
year |
denotes |
2019 |
| tok147 |
885-886 |
: |
denotes |
- |
| tok148 |
886-890 |
NN |
denotes |
nCoV |
| tok149 |
890-891 |
NN |
denotes |
/ |
| tok150 |
891-900 |
NNP |
denotes |
SARS-CoV- |
| tok151 |
900-901 |
CD |
denotes |
2 |
| tok152 |
902-908 |
NNS |
denotes |
shares |
| tok153 |
909-912 |
DT |
denotes |
the |
| tok154 |
913-920 |
JJS |
denotes |
highest |
| tok155 |
921-931 |
NN |
denotes |
nucleotide |
| tok156 |
932-940 |
NN |
denotes |
sequence |
| tok157 |
941-949 |
NN |
denotes |
identity |
| tok158 |
950-954 |
IN |
denotes |
with |
| tok159 |
955-963 |
NNP |
denotes |
SARS-CoV |
| tok160 |
964-965 |
( |
denotes |
( |
| tok161 |
965-967 |
CD |
denotes |
79 |
| tok162 |
967-968 |
. |
denotes |
. |
| tok163 |
968-969 |
CD |
denotes |
7 |
| tok164 |
969-970 |
NN |
denotes |
% |
| lookup16 |
969-970 |
percent |
denotes |
% |
| tok165 |
970-971 |
) |
denotes |
) |
| tok166 |
971-972 |
. |
denotes |
. |
| tok167 |
973-985 |
RB |
denotes |
Specifically |
| tok168 |
985-986 |
, |
denotes |
, |
| tok169 |
987-990 |
DT |
denotes |
the |
| tok170 |
991-999 |
NN |
denotes |
envelope |
| tok171 |
1000-1003 |
CC |
denotes |
and |
| tok172 |
1004-1016 |
NN |
denotes |
nucleocapsid |
| tok173 |
1017-1025 |
NNS |
denotes |
proteins |
| tok174 |
1026-1028 |
IN |
denotes |
of |
| tok175 |
1029-1033 |
CD |
denotes |
2019 |
| lookup17 |
1029-1033 |
year |
denotes |
2019 |
| tok176 |
1033-1034 |
: |
denotes |
- |
| tok177 |
1034-1038 |
NN |
denotes |
nCoV |
| tok178 |
1038-1039 |
NN |
denotes |
/ |
| tok179 |
1039-1048 |
NNP |
denotes |
SARS-CoV- |
| tok180 |
1048-1049 |
CD |
denotes |
2 |
| tok181 |
1050-1053 |
VBP |
denotes |
are |
| tok182 |
1054-1057 |
CD |
denotes |
two |
| lookup18 |
1054-1057 |
time |
denotes |
two |
| lookup19 |
1054-1057 |
number |
denotes |
two |
| tok183 |
1058-1072 |
RB |
denotes |
evolutionarily |
| tok184 |
1073-1082 |
JJ |
denotes |
conserved |
| tok185 |
1083-1090 |
NNS |
denotes |
regions |
| tok186 |
1090-1091 |
, |
denotes |
, |
| tok187 |
1092-1098 |
VBG |
denotes |
having |
| tok188 |
1099-1102 |
DT |
denotes |
the |
| tok189 |
1103-1111 |
NN |
denotes |
sequence |
| tok190 |
1112-1122 |
NNS |
denotes |
identities |
| tok191 |
1123-1125 |
IN |
denotes |
of |
| tok192 |
1126-1128 |
CD |
denotes |
96 |
| tok193 |
1128-1129 |
NN |
denotes |
% |
| lookup20 |
1128-1129 |
percent |
denotes |
% |
| tok194 |
1130-1133 |
CC |
denotes |
and |
| tok195 |
1134-1136 |
CD |
denotes |
89 |
| tok196 |
1136-1137 |
. |
denotes |
. |
| tok197 |
1137-1138 |
CD |
denotes |
6 |
| tok198 |
1138-1139 |
NN |
denotes |
% |
| lookup21 |
1138-1139 |
percent |
denotes |
% |
| tok199 |
1139-1140 |
, |
denotes |
, |
| tok200 |
1141-1153 |
RB |
denotes |
respectively |
| tok201 |
1153-1154 |
, |
denotes |
, |
| tok202 |
1155-1163 |
VBN |
denotes |
compared |
| tok203 |
1164-1166 |
TO |
denotes |
to |
| lookup22 |
1164-1166 |
country_code |
denotes |
to |
| tok204 |
1167-1175 |
NNP |
denotes |
SARS-CoV |
| tok205 |
1175-1176 |
. |
denotes |
. |
| tok206 |
1177-1182 |
VBG |
denotes |
Using |
| tok207 |
1183-1190 |
NN |
denotes |
network |
| tok208 |
1191-1200 |
NN |
denotes |
proximity |
| tok209 |
1201-1209 |
NNS |
denotes |
analyses |
| tok210 |
1210-1212 |
IN |
denotes |
of |
| tok211 |
1213-1217 |
NN |
denotes |
drug |
| tok212 |
1218-1225 |
NNS |
denotes |
targets |
| tok213 |
1226-1229 |
CC |
denotes |
and |
| tok214 |
1230-1239 |
NNP |
denotes |
HCoV-host |
| tok215 |
1240-1252 |
NNS |
denotes |
interactions |
| tok216 |
1253-1255 |
IN |
denotes |
in |
| lookup23 |
1253-1255 |
country_code |
denotes |
in |
| tok217 |
1256-1259 |
DT |
denotes |
the |
| tok218 |
1260-1265 |
JJ |
denotes |
human |
| tok219 |
1266-1277 |
NN |
denotes |
interactome |
| tok220 |
1277-1278 |
, |
denotes |
, |
| tok221 |
1279-1281 |
PRP |
denotes |
we |
| tok222 |
1282-1292 |
NN |
denotes |
prioritize |
| tok223 |
1293-1295 |
CD |
denotes |
16 |
| tok224 |
1296-1305 |
JJ |
denotes |
potential |
| tok225 |
1306-1311 |
NN |
denotes |
anti- |
| tok226 |
1311-1315 |
NNP |
denotes |
HCoV |
| tok227 |
1316-1328 |
JJ |
denotes |
repurposable |
| tok228 |
1329-1334 |
NNS |
denotes |
drugs |
| tok229 |
1335-1336 |
( |
denotes |
( |
| tok230 |
1336-1337 |
SYM |
denotes |
e |
| tok231 |
1337-1338 |
. |
denotes |
. |
| tok232 |
1338-1339 |
SYM |
denotes |
g |
| tok233 |
1339-1340 |
. |
denotes |
. |
| tok234 |
1340-1341 |
, |
denotes |
, |
| tok235 |
1342-1351 |
NN |
denotes |
melatonin |
| tok236 |
1351-1352 |
, |
denotes |
, |
| tok237 |
1353-1367 |
NN |
denotes |
mercaptopurine |
| tok238 |
1367-1368 |
, |
denotes |
, |
| tok239 |
1369-1372 |
CC |
denotes |
and |
| tok240 |
1373-1382 |
JJ |
denotes |
sirolimus |
| tok241 |
1382-1383 |
) |
denotes |
) |
| tok242 |
1384-1388 |
WDT |
denotes |
that |
| tok243 |
1389-1392 |
VBP |
denotes |
are |
| tok244 |
1393-1400 |
JJ |
denotes |
further |
| tok245 |
1401-1410 |
JJ |
denotes |
validated |
| tok246 |
1411-1413 |
IN |
denotes |
by |
| lookup24 |
1411-1413 |
country_code |
denotes |
by |
| tok247 |
1414-1424 |
NN |
denotes |
enrichment |
| tok248 |
1425-1433 |
NNS |
denotes |
analyses |
| tok249 |
1434-1436 |
IN |
denotes |
of |
| tok250 |
1437-1446 |
JJ |
denotes |
drug-gene |
| lookup25 |
1442-1446 |
person_first |
denotes |
gene |
| tok251 |
1447-1457 |
NNS |
denotes |
signatures |
| tok252 |
1458-1461 |
CC |
denotes |
and |
| tok253 |
1462-1474 |
NNP |
denotes |
HCoV-induced |
| tok254 |
1475-1490 |
NNS |
denotes |
transcriptomics |
| tok255 |
1491-1495 |
NNS |
denotes |
data |
| tok256 |
1496-1498 |
IN |
denotes |
in |
| lookup26 |
1496-1498 |
country_code |
denotes |
in |
| tok257 |
1499-1504 |
JJ |
denotes |
human |
| tok258 |
1505-1509 |
NN |
denotes |
cell |
| tok259 |
1510-1515 |
NNS |
denotes |
lines |
| tok260 |
1515-1516 |
. |
denotes |
. |
| tok261 |
1517-1519 |
PRP |
denotes |
We |
| lookup27 |
1517-1519 |
stop |
denotes |
We |
| tok262 |
1520-1527 |
JJ |
denotes |
further |
| tok263 |
1528-1536 |
VB |
denotes |
identify |
| event2 |
1528-1536 |
OCCURRENCE |
denotes |
identify |
| tok264 |
1537-1542 |
CD |
denotes |
three |
| lookup28 |
1537-1542 |
time |
denotes |
three |
| lookup29 |
1537-1542 |
number |
denotes |
three |
| tok265 |
1543-1552 |
JJ |
denotes |
potential |
| tok266 |
1553-1557 |
NN |
denotes |
drug |
| tok267 |
1558-1570 |
NNS |
denotes |
combinations |
| tok268 |
1571-1572 |
( |
denotes |
( |
| tok269 |
1572-1573 |
SYM |
denotes |
e |
| tok270 |
1573-1574 |
. |
denotes |
. |
| tok271 |
1574-1575 |
SYM |
denotes |
g |
| tok272 |
1575-1576 |
. |
denotes |
. |
| tok273 |
1576-1577 |
, |
denotes |
, |
| tok274 |
1578-1587 |
JJ |
denotes |
sirolimus |
| tok275 |
1588-1592 |
CC |
denotes |
plus |
| tok276 |
1593-1605 |
NN |
denotes |
dactinomycin |
| tok277 |
1605-1606 |
, |
denotes |
, |
| tok278 |
1607-1621 |
NN |
denotes |
mercaptopurine |
| tok279 |
1622-1626 |
CC |
denotes |
plus |
| tok280 |
1627-1636 |
NN |
denotes |
melatonin |
| tok281 |
1636-1637 |
, |
denotes |
, |
| tok282 |
1638-1641 |
CC |
denotes |
and |
| tok283 |
1642-1652 |
NN |
denotes |
toremifene |
| tok284 |
1653-1657 |
CC |
denotes |
plus |
| tok285 |
1658-1664 |
NN |
denotes |
emodin |
| tok286 |
1664-1665 |
) |
denotes |
) |
| tok287 |
1666-1674 |
VBN |
denotes |
captured |
| event16 |
1666-1674 |
OCCURRENCE |
denotes |
captured |
| tok288 |
1675-1677 |
IN |
denotes |
by |
| lookup30 |
1675-1677 |
country_code |
denotes |
by |
| tok289 |
1678-1681 |
DT |
denotes |
the |
| tok290 |
1682-1683 |
'' |
denotes |
" |
| tok291 |
1683-1696 |
NNP |
denotes |
Complementary |
| tok292 |
1697-1705 |
NNP |
denotes |
Exposure |
| tok293 |
1705-1706 |
'' |
denotes |
" |
| tok294 |
1707-1714 |
NN |
denotes |
pattern |
| tok295 |
1714-1715 |
: |
denotes |
: |
| tok296 |
1716-1719 |
DT |
denotes |
the |
| tok297 |
1720-1727 |
NNS |
denotes |
targets |
| tok298 |
1728-1730 |
IN |
denotes |
of |
| tok299 |
1731-1734 |
DT |
denotes |
the |
| tok300 |
1735-1740 |
NNS |
denotes |
drugs |
| tok301 |
1741-1745 |
DT |
denotes |
both |
| tok302 |
1746-1749 |
VBD |
denotes |
hit |
| event14 |
1746-1749 |
OCCURRENCE |
denotes |
hit |
| tok303 |
1750-1753 |
DT |
denotes |
the |
| tok304 |
1754-1763 |
NNP |
denotes |
HCoV-host |
| tok305 |
1764-1774 |
NN |
denotes |
subnetwork |
| tok306 |
1774-1775 |
, |
denotes |
, |
| tok307 |
1776-1779 |
CC |
denotes |
but |
| tok308 |
1780-1786 |
VB |
denotes |
target |
| event10 |
1780-1786 |
OCCURRENCE |
denotes |
target |
| tok309 |
1787-1795 |
JJ |
denotes |
separate |
| tok310 |
1796-1809 |
NNS |
denotes |
neighborhoods |
| tok311 |
1810-1812 |
IN |
denotes |
in |
| lookup31 |
1810-1812 |
country_code |
denotes |
in |
| tok312 |
1813-1816 |
DT |
denotes |
the |
| tok313 |
1817-1822 |
JJ |
denotes |
human |
| tok314 |
1823-1834 |
NN |
denotes |
interactome |
| tok315 |
1835-1842 |
NN |
denotes |
network |
| tok316 |
1842-1843 |
. |
denotes |
. |
| tok317 |
1844-1846 |
IN |
denotes |
In |
| tok318 |
1847-1854 |
NN |
denotes |
summary |
| tok319 |
1854-1855 |
, |
denotes |
, |
| tok320 |
1856-1860 |
DT |
denotes |
this |
| lookup32 |
1856-1860 |
time_modifier |
denotes |
this |
| tok321 |
1861-1866 |
NN |
denotes |
study |
| tok322 |
1867-1873 |
VBZ |
denotes |
offers |
| tok323 |
1874-1882 |
JJ |
denotes |
powerful |
| tok324 |
1883-1896 |
JJ |
denotes |
network-based |
| tok325 |
1897-1910 |
NNS |
denotes |
methodologies |
| tok326 |
1911-1914 |
IN |
denotes |
for |
| tok327 |
1915-1920 |
JJ |
denotes |
rapid |
| tok328 |
1921-1935 |
NN |
denotes |
identification |
| tok329 |
1936-1938 |
IN |
denotes |
of |
| tok330 |
1939-1948 |
NN |
denotes |
candidate |
| lookup33 |
1939-1948 |
jobtitle |
denotes |
candidate |
| tok331 |
1949-1961 |
JJ |
denotes |
repurposable |
| tok332 |
1962-1967 |
NNS |
denotes |
drugs |
| tok333 |
1968-1971 |
CC |
denotes |
and |
| tok334 |
1972-1981 |
JJ |
denotes |
potential |
| tok335 |
1982-1986 |
NN |
denotes |
drug |
| tok336 |
1987-1999 |
NNS |
denotes |
combinations |
| tok337 |
2000-2009 |
VBG |
denotes |
targeting |
| event8 |
2000-2009 |
OCCURRENCE |
denotes |
targeting |
| tok338 |
2010-2014 |
CD |
denotes |
2019 |
| lookup34 |
2010-2014 |
year |
denotes |
2019 |
| tok339 |
2014-2015 |
: |
denotes |
- |
| tok340 |
2015-2019 |
NN |
denotes |
nCoV |
| tok341 |
2019-2020 |
NN |
denotes |
/ |
| tok342 |
2020-2029 |
NNP |
denotes |
SARS-CoV- |
| tok343 |
2029-2030 |
CD |
denotes |
2 |
| tok344 |
2030-2031 |
. |
denotes |
. |
